Skip to main content
Erschienen in: Journal of Genetic Counseling 2/2018

08.02.2018 | Original Research

A Two-Phase Approach to Developing SNAP: an iPhone Application to Support Appointment Scheduling and Management for Women with a BRCA Mutation

verfasst von: Courtney Lynam Scherr, Jessica L. Feuston, Dawn M. Nixon, Stephanie A. Cohen

Erschienen in: Journal of Genetic Counseling | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Professional organizations provide surveillance guidelines for BRCA1 and BRCA2 (BRCA) carriers with intact breasts and/or ovaries to facilitate early cancer detection. However, literature indicates adherence to surveillance guidelines is inconsistent at best. Using the Messaging Model for Health Communication Campaigns framework, we undertook a two-phase formative research approach to develop an intervention to promote adherence to surveillance guidelines. Discussion groups identified preferred intervention format and function in phase I. Findings indicated carriers desired a phone application (app) to assist with surveillance management and appointment tracking. Thus, an iPhone app for carriers to track appointments based on published surveillance guidelines was developed. In phase II, we obtained feedback from BRCA carriers via a survey during a prototype demonstration at a regional conference. Participants in phase II wanted reminder capabilities and the ability to add and modify information fields. This feedback informed intervention modifications, resulting in the Scheduling Necessary Advised Procedures (SNAP) iPhone app currently being pilot tested by BRCA carriers throughout the USA.
Literatur
Zurück zum Zitat Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., … McDonald, J. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics Part A, 118(3), 201–209. Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., … McDonald, J. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics Part A, 118(3), 201–209.
Zurück zum Zitat Cohen, S. A., & McIlvried, D. E. (2012). Do BRCA1 and BRCA2 positive women need better follow-up? Gaining perspective from a Midwest population. Paper presented at the Poster presented at the Thirty First Annual Education Conference fo the National Society of Genetic Counselors, Boston. Cohen, S. A., & McIlvried, D. E. (2012). Do BRCA1 and BRCA2 positive women need better follow-up? Gaining perspective from a Midwest population. Paper presented at the Poster presented at the Thirty First Annual Education Conference fo the National Society of Genetic Counselors, Boston.
Zurück zum Zitat Daly, M. B., Pilarski, R., Axilbund, J., Berry, M., Buys, S. S., Crawford, B., … Khan, S. (2016). Genetic/familial high-risk assessment. JNCCN Journal of the National Comprehensive Cancer Network, 14(2), 153–162. Daly, M. B., Pilarski, R., Axilbund, J., Berry, M., Buys, S. S., Crawford, B., … Khan, S. (2016). Genetic/familial high-risk assessment. JNCCN Journal of the National Comprehensive Cancer Network, 14(2), 153–162.
Zurück zum Zitat Garcia, C., Wendt, J., Lyon, L., Jones, J., Littell, R. D., Armstrong, M. A., … Powell, C. B. (2014). Risk management options elected by women after testing positive for a BRCA mutation. Gynecologic Oncology, 132(2), 428–433. Garcia, C., Wendt, J., Lyon, L., Jones, J., Littell, R. D., Armstrong, M. A., … Powell, C. B. (2014). Risk management options elected by women after testing positive for a BRCA mutation. Gynecologic Oncology, 132(2), 428–433.
Zurück zum Zitat Mattson, M., & Basu, A. (2010). Centers for disease control’s diethylstilbestrol update: a case for effective operationalization of messaging in social marketing practice. Health Promotion Practice, 11(4), 580–588.CrossRefPubMed Mattson, M., & Basu, A. (2010). Centers for disease control’s diethylstilbestrol update: a case for effective operationalization of messaging in social marketing practice. Health Promotion Practice, 11(4), 580–588.CrossRefPubMed
Zurück zum Zitat Palmer, E. (1981). Shaping persuasive messages with formative research. In R. E. Rice & W. Paisley (Eds.), Public communication campaigns (pp. 227–238). Beverly Hills: Sage. Palmer, E. (1981). Shaping persuasive messages with formative research. In R. E. Rice & W. Paisley (Eds.), Public communication campaigns (pp. 227–238). Beverly Hills: Sage.
Zurück zum Zitat Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology Biomarkers & Prevention, 11(10), 1115–1118. Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology Biomarkers & Prevention, 11(10), 1115–1118.
Zurück zum Zitat Phillips, K. A., Jenkins, M. A., Lindeman, G. J., McLachlan, S. A., McKinley, J. M., Weideman, P. C., … Friedlander, M. L. (2006). Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clinical Genetics, 70(3), 198–206. Phillips, K. A., Jenkins, M. A., Lindeman, G. J., McLachlan, S. A., McKinley, J. M., Weideman, P. C., … Friedlander, M. L. (2006). Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clinical Genetics, 70(3), 198–206.
Zurück zum Zitat Rothstein, M. A. (2016). Some lingering concerns about the precision medicine initiative. Journal of Law, Medicine and Ethics, 3(44), 520–525.CrossRef Rothstein, M. A. (2016). Some lingering concerns about the precision medicine initiative. Journal of Law, Medicine and Ethics, 3(44), 520–525.CrossRef
Zurück zum Zitat Schwartz, M. D., Kaufman, E., Peshkin, B. N., Isaacs, C., Hughes, C., DeMarco, T., … Lerman, C. (2003). Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology, 21(21), 4034–4041. Schwartz, M. D., Kaufman, E., Peshkin, B. N., Isaacs, C., Hughes, C., DeMarco, T., … Lerman, C. (2003). Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology, 21(21), 4034–4041.
Zurück zum Zitat Van den Akker, J. (1999). Principles and methods of development research. Design approaches and tools in education and training (pp. 1–14): Springer. Van den Akker, J. (1999). Principles and methods of development research. Design approaches and tools in education and training (pp. 1–14): Springer.
Metadaten
Titel
A Two-Phase Approach to Developing SNAP: an iPhone Application to Support Appointment Scheduling and Management for Women with a BRCA Mutation
verfasst von
Courtney Lynam Scherr
Jessica L. Feuston
Dawn M. Nixon
Stephanie A. Cohen
Publikationsdatum
08.02.2018
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 2/2018
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0222-z

Weitere Artikel der Ausgabe 2/2018

Journal of Genetic Counseling 2/2018 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.